In this opening episode titled, ‘Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Clinical Burden and Diagnostic Challenges,’ moderator, Dr. Ryan Haumschild, and panelist, Dr. Kevin Alexander, ...
In this episode titled, ‘Economic Impact and Unmet Needs in ATTR-CM,’ Dr. Alexander outlines the key cost drivers of ATTR-CM from a clinical perspective, noting that patients typically see 4 to 5 ...
Health inequities add $360 billion yearly; see how employers uncover disparities in claims, rethink deductibles, and invest in prevention to curb costs.
The management of smoldering multiple myeloma (MM) is undergoing a significant transformation, driven by growing evidence that early intervention can meaningfully delay progression to active disease.
From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope ...
Bidisha Mandal, PhD, a professor at Washington State University, continued the conversation about her study, “Telehealth for Primary and Preventive Care Among Food-Insecure Individuals,” recently ...
The federal IACC, created in 2006, provides nonbinding guidance that helps align national autism research and services and supports coordination of approximately $2 billion in annual government ...
Published in JAMA Network Open, the study found that women with breast cancer living in Medicaid expansion states had a 4.8% lower risk of death compared with those in nonexpansion states. Researchers ...
From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope every viewer, near or far, takes home.
Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
Glaucoma medication adherence and glaucoma-related distress were both improved when patients used the Support, Educate, Empower (SEE) glaucoma coaching program vs the standard written education ...
Jody L. Green, PhD, explains how regulatory decisions shape medication safety amid uptake of OTC drugs. Green also highlights ...